UC San Francisco researchers conducted a phase 1 clinical trial to determine whether radioligand therapy combined with immunotherapy would benefit patients with metastatic castration resistant prostate cancer.
The Bay Area Breast Cancer Forum, led by Dr. Hope Rugo, has long provided an opportunity for patients, providers, clinical research coordinators, and community members to hear the latest in breast cancer research and treatment recommendations from UCSF experts.
UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone.
Last March, the Society for Neuro-Oncology (SNO) and Oxford University Press named UCSF neuro-oncologist Susan Chang, MD, Editor-in-Chief of its flagship journal Neuro-Oncology.
During Breast Cancer Awareness Month, we asked Dr. Laura J. Esserman about risk factors, progress in the field, and the importance of tailoring treatment for women with low-risk cancer while also identifying women at high risk of invasive cancer.
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher levels of these chemicals in their bodies.
Lena Winestone, MD, MSHP, UCSF Assistant Professor of Pediatrics, studies access to care for children with cancer and says that insights into racial, ethnic, and socioeconomic disparities can reveal ways for interventions to better support vulnerable populations.
From medical school, to cancer research coordinator, to PhD program, the pathway of scholar Sarah Kutika Nyagabona MD, Mmed Clinical Oncology, exemplifies the power of collaboration and mentorship in shaping a new generation of oncologists across the globe.